UPDATE : Tuesday, September 17, 2019
상단여백
Combo drugs: latest trend in local pharmaceuticals
Domestic pharmaceutical companies are actively developing combination drugs...
by Lee Hye-seon  |  2019-08-19 16:02
라인
Boryung to sell antihypertensive drugs in Mexico
Boryung Pharmaceutical said the company would sell its antihypertensive com...
by Lee Han-soo  |  2019-08-19 14:31
라인
Rivalry among PARP inhibitors intense in ovarian cancer treatment
Pharmaceutical firms’ war using PARP inhibitors, a group of pharmacological...
by Kim Yun-mi  |  2019-08-19 14:00
라인
Local drugmakers speed up NASH drug development
Domestic pharmaceutical companies are rushing to develop a treatment for no...
by Lee Hye-seon  |  2019-08-16 13:52
라인
Theragen Etex turns profitable after marking record Q2 sales
Theragen Etex said Tuesday that the company and its subsidiaries recorded c...
by Lee Han-soo  |  2019-08-14 17:22
라인
AstraZeneca wins expanded indication for type 2 diabetes treatment Forxiga
AstraZeneca said that it has received an expanded indication approval for F...
by Lee Han-soo  |  2019-08-14 16:17
라인
Korean firms eyeing on growing orphan drug market
Investigational drugs developed by Korean pharmaceutical companies are incr...
by Jeong Sae-im  |  2019-08-14 14:48
라인
Huons Global hits record-high 1H sales
Huons Global said Wednesday the company and its subsidiaries recorded 209.6...
by Lee Han-soo  |  2019-08-14 14:46
라인
Court dismisses Kolon's petition to suspend government's step on Invossa
A local court has rejected a petition made by Kolon Life Science to suspend...
by Lee Han-soo  |  2019-08-14 11:57
라인
Hugel posts ₩50.3 billion in Q2 sales
Hugel said that it recorded 50.3 billion won ($41.1 million) in sales in th...
by Lee Han-soo  |  2019-08-13 18:13
라인
Last trial OKed for Eylea to prevent blindness in premature infants
The Korean drug regulator has approved a phase-3 clinical trial on Eylea (i...
by Lee Hye-seon  |  2019-08-13 12:42
라인
Daewoong's idiopathic pulmonary fibrosis treatment wins orphan drug status
Daewoong Pharmaceutical said that the U.S. Food and Drug Administration has...
by Lee Han-soo  |  2019-08-13 11:12
라인
Roche wins additional indication for breast cancer treatment Kadcyla
Roche Korea said that it has received additional indication approval for Ka...
by Lee Han-soo  |  2019-08-12 15:17
라인
Yuhan can continue testing lung cancer drug Lazertinib
Four deaths occurred during Yuhan Corp.’s clinical trial on new lung cancer...
by Lee Hye-seon  |  2019-08-12 12:58
라인
Kolmar CEO steps down, apologizes for controversial video
Kolmar Korea CEO Yoon Dong-han, the owner of the nation’s largest manufactu...
by Lee Han-soo  |  2019-08-12 11:11
라인
Kolmar apologizes for playing controversial YouTube clip
Kolmar Korea, the nation’s largest manufacturer of cosmetic products which ...
by Lee Han-soo  |  2019-08-09 16:48
라인
Diabetes drug Jardiance pressures heart failure treatment Entresto
Novartis’ new heart failure treatment Entresto (ingredient: sacubitril/vals...
by Kim Yun-mi  |  2019-08-09 15:44
라인
AstraZeneca’s Lynparza show positive results for prostate cancer in P3 trial
AstraZeneca and MSD announced positive results from their phase 3 PROfound ...
by Lee Han-soo  |  2019-08-08 16:48
라인
‘CPhI Korea thriving on local firms’ zeal for drug export’
Korea Pharmaceutical Traders Association (KPTA) said it would open a large-...
by Jeong Sae-im  |  2019-08-08 14:54
라인
Hanmi’s US partner unveils P3 data on oral anticancer drug
Athenex, Hanmi’s U.S. partner, presented the topline data showing that Orax...
by Lee Han-soo  |  2019-08-08 14:53
여백
여백
여백
Back to Top